Long-Term Use of Glatiramer Acetate by 11 Pregnant Women with Multiple Sclerosis: A Retrospective, Multicentre Case Series

Author： Fragoso Yára D.

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.24, Iss.11, 2010-11, pp. : 969-976

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glatiramer acetate for the treatment of multiple sclerosis

By Wolinsky Jerry S

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 875-891

Informa Healthcare

Access to resources Recommend Favorite

Glatiramer acetate in the treatment of multiple sclerosis

By Sela Michael Teitelbaum Dvora

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 7, 2001-07 ,pp. : 1149-1165

Informa Healthcare

Access to resources Recommend Favorite

Glatiramer Acetate: A Review of its Use in Relapsing-Remitting Multiple Sclerosis

By Simpson D. Noble S. Perry C.

CNS Drugs, Vol. 16, Iss. 12, 2002-01 ,pp. : 825-850

Adis International

Access to resources Recommend Favorite

Glatiramer Acetate: A Review of its Use in Relapsing-Remitting Multiple Sclerosis and in Delaying the Onset of Clinically Definite Multiple Sclerosis

By Carter Natalie J. Keating Gillian M.

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1545-1577

Adis International

Access to resources Recommend Favorite

Risk-Benefit Assessment of Glatiramer Acetate in Multiple Sclerosis

By Ziemssen T.

Drug Safety, Vol. 24, Iss. 13, 2001-01 ,pp. : 979-990

Adis International

Access to resources Recommend Favorite